BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10981360)

  • 1. Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis.
    Farrell RJ; LaMont JT
    Curr Top Microbiol Immunol; 2000; 250():109-25. PubMed ID: 10981360
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.
    Hookman P; Barkin JS
    Dig Dis Sci; 2007 Apr; 52(4):1071-5. PubMed ID: 17380404
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium difficile infection: a comprehensive review.
    Kachrimanidou M; Malisiovas N
    Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile in children: colonisation and disease.
    Enoch DA; Butler MJ; Pai S; Aliyu SH; Karas JA
    J Infect; 2011 Aug; 63(2):105-13. PubMed ID: 21664931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infections caused by Clostridium difficile].
    Rodríguez-Pardo D; Mirelis B; Navarro F
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):254-63. PubMed ID: 23411363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxin production by and adhesive properties of Clostridium difficile isolated from humans and horses with antibiotic-associated diarrhea.
    Taha S; Johansson O; Rivera Jonsson S; Heimer D; Krovacek K
    Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):163-74. PubMed ID: 17239950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Clostridium difficile-associated diarrhea and colitis.
    Gerding DN
    Curr Top Microbiol Immunol; 2000; 250():127-39. PubMed ID: 10981361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.
    Khanna S; Pardi DS
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):409-16. PubMed ID: 20678014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence of Clostridium difficile toxin A negative strains.
    Wilcox MH; Fawley WN
    J Hosp Infect; 2001 May; 48(1):81. PubMed ID: 11358476
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
    Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
    Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Clostridium difficile-associated intestinal disease.
    Rolfe RD
    Crit Rev Clin Lab Sci; 1986; 24(3):235-61. PubMed ID: 3539522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.
    Komatsu M; Kato H; Aihara M; Shimakawa K; Iwasaki M; Nagasaka Y; Fukuda S; Matsuo S; Arakawa Y; Watanabe M; Iwatani Y
    Eur J Clin Microbiol Infect Dis; 2003 Sep; 22(9):525-9. PubMed ID: 12938013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent changes in Clostridium difficile infection.
    Silva Júnior M
    Einstein (Sao Paulo); 2012; 10(1):105-9. PubMed ID: 23045838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
    Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
    World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy.
    Adler SP; Chandrika T; Berman WF
    Am J Dis Child; 1981 Sep; 135(9):820-2. PubMed ID: 7282658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
    Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
    Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects.
    George WL
    Rev Infect Dis; 1984; 6 Suppl 1():S208-13. PubMed ID: 6372031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxin and enterotoxin production by Clostridium difficile.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
    Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk for Clostridium difficile colitis during hospitalization in asymptomatic carriers.
    Kagan S; Wiener-Well Y; Ben-Chetrit E; Kashat L; Aouizerats J; Bdolah-Abram T; Yinnon AM; Assous MV
    J Hosp Infect; 2017 Apr; 95(4):442-443. PubMed ID: 28202190
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of toxin A negative/B positive Clostridium difficile strains.
    Brazier JS; Stubbs SL; Duerden BI
    J Hosp Infect; 1999 Jul; 42(3):248-9. PubMed ID: 10440000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.